Reveals structural properties of zinc-induced amyloid β oligomers, suggesting mechanisms in Alzheimer's disease.
Divalent zinc ions (Zn) interact with amyloid β (Aβ) peptides and influence its Alzheimer disease (AD)-related aggregation. Little is known about the structural properties of Zn-induced Aβ oligomers. Here, we report recombinant production of fluorinated Aβ40 at Phe4, Tyr10, Phe19 and Phe20 residues and utilize these fluorinated residues as proxies to interrogate Zn-induced Aβ40 oligomers. Our NMR and CW EPR results confirm Zn binding to the N-terminal region of Aβ40 and demonstrate the reversible oligomerization and irreversible aggregation of Aβ40 upon Zn addition. The 19F NMR relaxation and dark-state exchange saturation transfer (DEST) data provide dynamical information on free Aβ40 and demonstrate that monomeric Aβ40 is in exchange with small Zn-induced Aβ40 oligomers with less than about 60 kDa molecular weight on a millisecond timescale. The 19F ENDOR data suggest that the distance between the N-terminally attached nitroxide spin and fluorinated residues within the Zn-Aβ40 aggregates is larger than about 1.5 nm. Our results shed light on the properties of soluble Zn-induced Aβ oligomers and pave the way for further structural characterization of these Aβ aggregates. Divalent zinc ions interact with amyloid β (Aβ) peptides and influence its Alzheimer disease-related aggregation, but the structural properties of Zn-induced Aβ oligomers remain underexplored. Here, the authors use fluorinated residues as proxies to interrogate Zn-induced Aβ40 oligomers, confirming that zinc binds to the N-terminal region of Aβ40 and demonstrating the reversible oligomerization and irreversible aggregation of Aβ40 upon zinc addition.
No takes yet. Share an insight, caveat, or question.
Russo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: